Nigeria has warned its citizens to be wary of the cough syrups linked to dozens of deaths of children in The Gambia.

The four syrups manufactured by Indian pharmaceutical company Maiden Pharmaceuticals are suspected to have been contaminated.

The products are Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup.

A World Health Organization report which noted that Maiden Pharmaceuticals had failed to provide guarantees about their safety, had earlier issued a global alert over the pediatric medicines.

Nigeria’s National Agency for Food Drug Administration and Control (Nafdac) has however enjoined the populace in Africa’s most populous country to avoid the said medicines.

In a statement, the agency says anyone who has used the “substandard products” or has suffered any adverse reaction, should seek immediate medical advice and report to the health authorities.

It says the effects of the toxic substances contained in the cough syrups include abdominal pain, vomiting, diarrhoea, inability to pass urine, headache and acute kidney injury which may lead to death.

But it has not said whether the syrups have been discovered to be in circulation in the country.

But Maiden, while reacting to the news said it was shocked and saddened over the incident, while saying that the company followed Indian health protocols and was co-operating with an investigation.

The Gambia has already started withdrawing the medicines from circulation while at least 69 deaths of children have been linked to the cough syrups in that country.

The WHO has however expressed fears that the Gambia might not be the only country where the cough syrups had been exported to.